FluoretiQ Limited the award-winning start-up, pioneering NANOPLEX a 15-minute proprietary diagnostic platform for bacterial infections today announced the completion of a £1.1 million, pre-series A investment

Introduction to the Infection Management Coalition White Paper  www.theIMC.org The Covid-19 pandemic has made people more conscious of their personal health than ever before and has created awareness of the devastating impact that infections can have. Indeed, those living with supressed immune systems may have already been far more aware of the fatal risks posed by infection. We have all now witnessed how our individual actions can impact the health of others, and how an infectious dis...

BIVDA welcomes the Secretary of State’s acknowledgement of the importance of diagnostics during the pandemic. Diagnostic testing is fundamental to cutting waiting lists, spotting life-threatening illnesses, and ensuring the UK clears the elective care backlog rapidly and efficiently. As has been noted, currently only 75% of people needing a diagnostic test received one within six weeks – a fall from 96% before the pandemic. We are encouraged by the Secretary of State’s goa...

First of its kind coalition sees health industry, professional bodies and experts come together to holistically tackle ‘hidden pandemic’ of antibiotic resistant infections  COVID-19 has shone a light on the need to consider infection management as a whole Coined as the ‘hidden pandemic’, concerns are rising that antibiotic resistant infections are already presenting the next global health crisis A whole system approach is required for the way infection is detected, m...

The amending regulation which extends the transitional provisions of the IVD Regulation has become EU law and comes into force from today. This is immediately applicable in all member states, and will allow for further preparation time for companies depending on device classification.Regulation (EU) 2022/112 extends the IVDR transitional periods, allowing most devices with their EC Declaration of Conformity under the IVD Directive to be placed on the market and or put into service for an additio...

A North East-based lab is celebrating one year since it was set up to accelerate the development of the next generation of virus testing

A new product developed between Bedford-based Life Science Group Ltd (LSG) and Coventry University has the potential to transform the delivery of cell and gene therapy and in the longer term make these cutting-edge, personalised treatments more accessible

The European IVD Market Statistics Report 2021 has just been published by MedTech Europe. The latest version of this annual report shows that revenues for IVDs increased by an unprecedented 25.4% across the EU27 member states (plus EFTA, the UK and Turkey) between 2019 and 2020. Most of this increase was due to COVID-19 related diagnostics, however there were significant increases in specific tests, and dramatic decreases in others which varied from country to country. For UK-specific data compa...

Please see the below press release which outlines the facts regarding the UK's capacity to manufacture lateral flow tests

For Immediate Release --BIVDA, the UK’s national association for the manufacturers and distributors of in vitro (IVD) products, welcomes the adoption of amended transitional provisions of the In Vitro Diagnostic Medical Devices Regulation.This decision will allow for a more workable transition for IVD sector companies to prepare for transition into the new European regulatory framework for IVD medical tests.On 20th December, the European Council confirmed their support in full of the propo...